Glatiramer acetate reduces the proportion of new MS lesions evolving into “black holes”
Massimo Filippi(Vita-Salute San Raffaele University), J. S. Wolinsky(National Cancer Research Institute), Gıancarlo Comı(Vita-Salute San Raffaele University), Marco Rovaris(San Raffaele University of Rome), Maria Pia Sormani(University of Genoa), Maria A. Rocca(Cognitive Neuroimaging Lab)
Cited by 245
Related Papers
Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria
|Annals of Neurology|2011|9.8k
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
|The Lancet Neurology|2017|8k
Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”
|Annals of Neurology|2005|5k
Defining the clinical course of multiple sclerosis
|Neurology|2014|3.1k
Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis
|New England Journal of Medicine|2010|2.2k